SeaStar Medical Holding Corp

For the period ended Dec 31, 2024. Filed Mar 27, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 27, 2025

ICU$1.90-3.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets as of December 31, 2024 and

As of December 31, 2024 and 2023

	2024	2023
ASSETS
Current assets
Cash	$1,819	$176
Accounts receivable	112	—
Prepaid expenses	1,835	2,132
Total current assets	3,766	2,308
Other assets	892	1,205
Total assets	$4,658	$3,513
LIABILITIES AND STOCKHOLDERS̕ DEFICIT
Current liabilities
Accounts payable	$3,046	$4,372
Accrued expenses	3,188	1,523
Contract liabilities	—	100
Notes payable, net of deferred financing costs	574	565
Convertible notes, current portion	—	4,179
Liability classified warrants	33	2,307
Total current liabilities	6,841	13,046
Notes payable, net of deferred financing costs	—	4,143
Convertible notes, net of current portion	—	194
Total liabilities	6,841	17,383
Commitments and contingencies (Note 13)
Stockholders̕ deficit
Preferred stock - $0.0001 par value, 10,000,000 shares authorized at December 31, 2024 and 2023; no shares issued and outstanding at December 31, 2024 and 2023.	—	—
Common stock - $0.0001 par value per share; 500,000,000 shares authorized at December 31, 2024 and 2023; 5,977,246 and 2,016,045 shares issued and outstanding at December 31, 2024 and 2023, respectively	2	1
Additional paid-in capital	137,379	100,863
Accumulated deficit	(139,564)	(114,734)
Total stockholders̕ deficit	(2,183)	(13,870)
Total liabilities and stockholders̕ deficit	$4,658	$3,513

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.